London Biotechnology Network

The London Biotechnology Network has recently merged with the Cambridge based ERBI group, to form the new entity now trading as One Nucleus. The enlarged membership organisation comprising of over 450 life science companies, represents a significant proportion of the UK's life science base and has a growing overseas membership contingent.  
 
London First continues to sponsor the network and its members can look forward to an improved range of benefits: 

  • debate key issues affecting the future development of the regional, national and international  life science sector via networking meetings in Cambridge and London along with the Genesis, Bench2Boardroom and One Nucleus partnering conferences
  • provide opportunities to bring its members together with other biotechnology clusters, both in the UK and overseas
  • showcase member companies seeking investment to the venture capital and Pharma community
  • respond to enquiries from inward investors seeking new business opportunitiesnegotiate special rates with suppliers such as business intelligence providers, conference organisers and journal publishers through collaborations and the One Nucelus Group Purchasing Scheme     
  • access the One Nucleus training courses and Spexcial Interest Groups
  • disseminate information and provide a key online portal including listings of companies, institutions, investors and professional service members of the network

One Nucleus activities include

Genesis – the UK’s leading biotechnology conference

Now in its tenth year, the annual Genesis conference is the UK's leading biotechnology conference. It attracts over 800 delegates and exhibitors from the UK and overseas, with presentations from industry leaders, a technology showcase and on-line partnering facilities. Genesis is an excellent opportunity to keep up to date with recent developments in the industry, forge new business relationships and raise awareness of your company to potential partners and investors.

LBN Career Track - aimed at emerging biopharma professionals, this initiative seeks to increases awareness of career opportunities in the sector.  

For further information, visit www.onenucleus.com or contact Tony Jones on 020 7665 1403.

Forthcoming events